Skip to main content

Table 3 Matched bivariate analysis between co-infected patients and pure dengue infected patients

From: Is dengue and malaria co-infection more severe than single infections? A retrospective matched-pair study in French Guiana

Results n (%)

Co-infection (n = 104)

N (%)

Dengue (n = 208)

N (%)

p*

Males

75 (72.1)

119 (57.2)

0.01§

Children (<15 years-old)

11 (10.6)

49 (23.6)

0.008§

Journey in forest

26 (25)

7 (3.4)

<0.001§

Living on the coast ¥

86 (83.5)

183 (92.9)

0.025§

Long admission (≥2 days)

43 (41.3)

71 (34.1)

0.23

Admission

37 (35.6)

45 (21.6)

0.01§

Medical history of malaria

52 (50)

21 (10.2)

<0.001§

Time since last malaria attack < 90 days

15 (44.1)

0 (0)

-

Medical history of dengue

3 (3.4)

5 (2.7)

0.64

Duration of fever > 5 days

48 (48.5)

33 (16.3)

<0.001§

Red cells transfusion

8 (7.7)

2 (1)

0.03§

Tachycardia (>90 bpm)

79 (79)

128 (64.6)

0.03§

Hypotension (<90 mmHg)

10 (10.4)

3 (1.8)

0.02§

Fever ≥ 40°C

15 (14.7)

10 (4.9)

0.006§

Retro-orbital pain

4 (3.9)

26 (12.6)

0.01§

Chills

36 (35.6)

37 (18)

0.002§

Hemorrhagic signs

12 (11.5)

32 (15.5)

0.31

Shock signs

7 (6.8)

5 (2.4)

0.06§§

Rash

1 (1)

30 (14.6)

0.007§

Neurological disorders

7 (6.8)

8 (3.9)

0.28

Nausea and / or vomiting

58 (56.9)

94 (45.6)

0.07§§

Dehydration

7 (7.4)

4 (1.9)

0.04§

Mucocutaneous pallor

11 (11.6)

3 (1.5)

0.003§

Splenomegaly

9 (12.3)

3 (3.1)

0.04§

Jaundice

9 (8.7)

6 (2.9)

0.03§

ENT symptoms

6 (5.8)

42 (20.2)

0.002§

Severe “malaria” cases ††

34 (32,7)

33 (15,9)

<0,001

Confirmed acute dengue cases

41 (39.4)

150 (72.1)

<0.001§

Mildly low hemoglobin (<12 g/dl)

37 (35.6)

40 (19.2)

0.002§

Low hematocrit (<36%)

43 (41.3)

34 (16.4)

<0.001§

Deep thrombocytopenia (<50 G/L)

23 (22.1)

6 (2.9)

<0.001§

Low prothrombin (<70%)

14 (21.2)

19 (13.9)

0.18§§

Hyponatremia (<130)

7 (7.1)

5 (2.5)

0.08§§

Hypokalemia (<3)

6 (6.1)

3 (1.5)

0.04§

Elevated creatinin (>111 μmol/L)

4 (4)

4 (2)

0.3

Elevated bilirubin (>50 μmol/L)

16 (16.8)

3 (1.6)

<0.001§

SGPT (>2 N)

10 (10.2)

32 (16)

0.2

SGOT >2 N

13 (13.3)

41 (20.5)

0.16§§

CRP <5

2 (2)

73 (35.3)

<0.001§

CRP 5 à 50

29 (29)

115 (55.6)

-

CRP > 50

69 (69)

19 (9.2)

-

  1. * p calculated with Wald test in matched bivariate analysis.
  2. § Significant p-values < 0.05.
  3. §§p-values < 0.2 included in the matched multivariate model
  4. bpm Beats per minute..
  5. ¥ People living on the coast are defined as people living in Cayenne, Rémire-Montjoly, Matoury Macouria, Kourou, Irakoubo or Mana. ; Other people declared to live in Cacao, Roura, Montsinnéry-Tonnégrande, Régina, Saül, St-Elie, Saint Laurent du Maroni, Apatou, Maripasoula, Papaïchton, St George de l’Oyapock, Camopi or Trois-Sauts. 4 people came from France, 1 from the French Caribbean and 1 from French Polynesia.
  6. Hemorrhagic signs included purpura, gingival bleeding, epistaxis, macroscopic hematuria, hematemesis, melena, rectal bleeding and hemoptysis.
  7. Signs of shock included systolic blood pressure <90 mmHg or not responding to IV fluids and with or without oliguria. ENT symptoms included diagnoses of rhinitis, nasopharyngitis, pharyngitis, sinusitis and otitis.
  8. †† WHO 2000 criteria for severe P. falciparum malaria [20].
  9. ENT Ear, Nose and Throat, SGPT Serum Glutamopyruvate Transferase, SGOT Serum Glutamooxaloacetate Transférase, CRP C-reactive protein.